Chelation therapy is a method of removing harmful metals from the body. The method has been known in Germany since 1983. In that year, doctors in Hamburg founded the German Medical Association for Chelation Therapy.
Doctors and environmental physicians with appropriate training are authorized to use the method. They follow the therapy protocol of the Medical Society for Clinical Metal Toxicology, KMT for short.
Chelation therapy owes its name to the Greek word "Chele". "Chele" means cancer scissors and is an allusion to the mode of action of the therapy. Like cancer scissors, the chelating agents envelop the heavy metals.
The chelating agents enclose the electrolyte and metal ions and prevent them from being deposited in the tissue. They bind the metal atom so that the kidneys break them down more quickly.
Various chemical compounds can be used as chelating agents:
- Ethylenediaminetetraacetic acid (EDTA): removes cadmium and mercury
- Dimercaptosuccinic acid (DMSA): helps with mercury
- Dimercaptopropanesulfonic acid (DMPS): for mercury, lead and arsenic
EDTA is used most frequently. Oral administration is also possible.
Chelation therapy is used for acute heavy metal poisoning (lead poisoning). Specialist doctors also use it to treat Wilson's disease. In this disease, copper metabolism is disturbed.
The bile excretes too little copper. The excess copper accumulates in the central nervous system, the eyes, the liver and other organs. There it causes damage.
The German Medical Association for Clinical Metal Toxicology refers to studies that prove the toxic effect of various metals.
According to these studies, even small amounts of mercury, arsenic, cadmium and lead promote the development of:
Chelation therapy therefore addresses the cause directly.
In addition, heavy metals prevent vital minerals such as magnesium, calcium and zinc from fulfilling their tasks in the human body.
Possible consequences are
Chelation therapy is also effective against an excess of iron. Iron is a valuable component of human nutrition. However, too much iron promotes the development of arteriosclerosis (vascular calcification) and promotes heart attacks and strokes.
Typical areas of application of chelation therapy are calcifications of the:
- Carotid artery
- abdominal aorta
- Coronary arteries
- Leg arteries
Many doctors use chelation therapy to prevent heart surgery (bypass) or amputation.
Supportive treatment for cancer and autoimmune diseases is also conceivable.
Chelation therapy is also suitable for aftercare following a stroke or heart operation. After a bypass operation, chelation therapy prevents renewed vascular occlusion.
Degenerative vascular diseases are a general area of application.
Chelation therapy is a method for the treatment and prevention of vascular, circulatory and neurological diseases @ TarikVision /AdobeStock
Before the treatment, the doctor determines the heavy metal load. To do this, he examines the urine, blood or starts a hair analysis.
Metal exposure often accumulates over the course of decades. If there is a toxic metal load, then therapy makes sense.
The therapy is carried out with the help of chelating agents known as chelates . These remove metal residues from the body. The chemical compounds attract the toxic metals like a magnet. The kidneys excrete them.
During chelation therapy, you receive around 25 infusions. Two treatments a week are usual. The number depends on the urgency.
Subsequently, maintenance therapy is advisable. You will receive an infusion once a month. An infusion takes about three to four hours. This long period is necessary to protect the kidneys.
The cost of an infusion is around 120 to 150 euros. Not every health insurance company covers the costs of this service. Chelation therapy is considered an alternative treatment method.
Chelation therapy is no more dangerous than other procedures. Since 1983, doctors have carried out over two million infusions in Germany alone. According to KMT, there have been no serious incidents to date. According to the TACT study conducted by the American health authority NIH, serious side effects are very rare.
Occasionally, a feeling of coldness, tiredness or a burning sensation at the infusion site may occur after treatment. An increased urge to urinate is also possible. Patients rarely suffer from restlessness, headaches and nausea.
However, treatment should be avoided in patients with dementia, untreated heart failure, infections treated with antibiotics and elevated kidney values.
The therapy also carries risks for people with severe cardiac arrhythmia and liver dysfunction. This also applies to patients with pulmonary TB and an extensive aneurysm (bulging of a blood vessel).
Women who are pregnant are best advisednot to undergo chelation therapy.
Several laboratory tests accompany the treatment. The doctor takes blood samples before the therapy, after several fusions and at the end. This ensures that the excretory organs such as the liver and kidneys are working properly.
It is also important to recognize a shift in electrolytes at an early stage. Thorough examinations reduce the risk of leaching of vital minerals and trace elements.
The doctor closely monitors the levels of calcium and other minerals in order to avoid a deficiency and any side effects. If this is not the case, he or she will take immediate action to compensate for the mineral deficiency.
As a rule, the chances of success are good and the symptoms usually disappear shortly after the end of the initial therapy. Depending on the illness, however, treatment may take months or years.
As already mentioned, maintenance therapy is worthwhile following treatment . This involves the patient receiving an infusion every month.
Many diseases can be traced back to heavy metal exposure. Chelation therapy as an alternative method prevents various diseases and even makes operations superfluous.